Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03672019 · ClinicalTrials.gov registry record
A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage
A clinical trial of Malignant Biliary Obstruction, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 118
- Enrollment target
- 5
- Study locations
NCT03672019: Active study of Malignant Biliary Obstruction, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03672019 is a study of Malignant Biliary Obstruction that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 118 participants. The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03672019, a study of Malignant Biliary Obstruction, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare the participant's health-related quality of life before and after the biliary drainage procedure. The study will also help us learn whether having a drainage catheter or a stent placed during the procedure makes a difference in the participant's quality of life.
Primary Outcome
The FACT-Hep minimum score is 0 and the maximum is 180.
Conditions Studied
Interventions
- BEHAVIORAL FACT-Hep
Study Locations (5)
New York
- Memorial Sloan Kettering Commack (Consent only) - Commack
- Memorial Sloan Kettering Westchester (Consent only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only) - Middletown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2018-09-11 |
| Est. Completion | 2026-09 |
What the registry record for NCT03672019 still lists
NCT03672019 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Malignant Biliary Obstruction appearing as the primary indexed condition, and to 1 intervention - of which FACT-Hep is the first listed.
NCT03672019 lists 5 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT03672019 about?
NCT03672019 is a clinical study titled "A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage". The purpose of this study is to compare the participant's health-related quality of life before and after the biliary drainage procedure. The study will also help us learn whether having a drainage catheter or a stent placed during the procedure makes a difference in the participant's quality of lif...
What is the current status of trial NCT03672019?
This trial is currently active not recruiting. The enrollment target is 118 participants. The study started on 2018-09-11. Estimated completion is 2026-09.
What conditions does trial NCT03672019 study?
This clinical trial studies the following conditions: Malignant Biliary Obstruction.
What interventions are being tested in trial NCT03672019?
The interventions under investigation include: FACT-Hep (BEHAVIORAL).
Who is sponsoring clinical trial NCT03672019?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03672019 being conducted?
This trial has 5 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI